Associate Professor, Neurology, University of Texas Medical School, Houston
Neurology
Dr. Sean I. Savitz, MD
|
|
Give Review
Doctor Sean I. Savitz, MD is an expert in the field of Neurology. He went to medical school at Albert Einstein College of Medicine of Yeshiva University. Sean Savitz is a published doctor and has 101 publications published. The lastest was: 'Various Cell Populations Within the Mononuclear Fraction of Bone Marrow Contribute to the Beneficial Effects of Autologous Bone Marrow Cell Therapy in a Rodent Stroke ...' He accepts Medicare.
Publications
- Autologous Bone Marrow Mononuclear Cells Exert Broad Effects on Short- and Long-Term Biological and Functional Outcomes in Rodents with IntraCerebral Hemorrhage.
- Decompressive hemicraniectomy with or without clot evacuation for large spontaneous supratentorial intraCerebral hemorrhages.
- Telemedicine-guided remote enrollment of patients into an acute Stroke trial.
- Misdiagnosis of cerebellar infarctions.
- Prehospital Utility of Rapid Stroke Evaluation Using In-Ambulance Telemedicine: A Pilot Feasibility Study.
- Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System.
- CTP infarct core may predict poor outcome in Stroke patients treated with IV t-PA.
- Racial and Gender Differences in Stroke Severity, Outcomes, and Treatment in Patients with Acute Ischemic Stroke.
- Impact of Telemedicine on Access to Acute Stroke Care in the State of Texas.
- Clotting Factors to Treat Thrombolysis-Related Symptomatic Intracranial Hemorrhage in Acute Ischemic Stroke.
- Stem Cells as an Emerging Paradigm in Stroke 3: Enhancing the Development of Clinical Trials.
- Mild acute ischaemic Stroke-the case for thrombolytic therapy.
- Predicting the need for hospital admission of TIA patients.
- CLOTBUST-Hands Free: Pilot Safety Study of a Novel Operator-Independent Ultrasound Device in Patients With Acute Ischemic Stroke.
- Intra-arterial Delivery Is Not Superior to Intravenous Delivery of Autologous Bone Marrow Mononuclear Cells in Acute Ischemic Stroke.
- The NIHSS Score and its Components can Predict Cortical Stroke.
- Optimizing Prediction Scores for Poor Outcome After Intra-Arterial Therapy in Anterior Circulation Acute Ischemic Stroke.
- Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in IntraCerebral Hemorrhage (SHRINC).
- Tissue-type plasminogen activator for Stroke mimics: continuing to be swift rather than delaying treatment to be sure.
- Changing demographics at a comprehensive Stroke center amidst the rise in primary Stroke centers.
- Posterior circulation Stroke is associated with prolonged door-to-needle time.
- Changes in spleen size in patients with acute ischemic Stroke: a pilot observational study.
- Advances in Stroke: emerging therapies.
- Stroke severity as well as time should determine Stroke patient triage.
- Challenges enrolling patients with acute ischemic Stroke into cell therapy trials.
- Patient refusal of thrombolytic therapy for suspected acute ischemic Stroke.
- Reviving Neuroprotection Using a New Approach: Targeting Postsynaptic Density-95 to Arrest Glutamate ExcitoToxicity.
- Ischemic Stroke May Activate Bone Marrow Mononuclear Cells to Enhance Recovery After Stroke.
- The Argatroban and Tissue-Type Plasminogen Activator Stroke Study: Final Results of a Pilot Safety Study.
- Intra-arterial Delivery of Cell Therapies for Stroke.
- Intracranial Atherosclerosis Is Associated with Progression of Neurological Deficit in Subcortical Stroke.
- Inflammatory response to intraventricular Hemorrhage: Time course, magnitude and effect of t-PA.
- Intravenous autologous bone marrow mononuclear cells for ischemic Stroke.
- Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic Stroke.
- Investigational Therapies for Ischemic Stroke: Neuroprotection and Neurorecovery.
- Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II.
- Pharmacological deep vein thrombosis prophylaxis does not lead to hematoma expansion in intraCerebral hemorrhage with intraventricular extension.
- Advances in emerging therapies 2010.
- Zero on the NIHSS does not equal the absence of Stroke.
- Increased blood-Brain barrier permeability on perfusion CT might predict malignant middle cerebral artery infarction.
- Effect of needle diameter and flow rate on rat and human mesenchymal stromal cell characterization and viability.
- Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic Stroke.
- Current practice versus willingness to enroll in clinical trials: paradox among vascular neurologists about treatment for acute ischemic Stroke.
- Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion Injury model.
- IntraCerebral hemorrhage in cocaine users.
- Autologous bone marrow mononuclear cells enhance recovery after acute ischemic Stroke in young and middle-aged rats.
- Intravenous tissue plasminogen activator in patients with cocaine-associated acute ischemic Stroke.
- Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect.
- Is the drip-and-ship approach to delivering thrombolysis for acute ischemic Stroke safe?
- Cosmic implications of NXY-059.
- Introduction to cellular therapy: the next frontier for Stroke therapeutics.
- Combined neuroprotective modalities coupled with thrombolysis in acute ischemic Stroke: a pilot study of caffeinol and mild hypothermia.
- The IVH score: a novel tool for estimating intraventricular Hemorrhage volume: clinical and research implications.
- Thrombolytic therapy for patients who wake-up with Stroke.
- Does study enrollment delay treatment with intravenous thrombolytics for acute ischemic Stroke?
- Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic Stroke trials.
- Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic Migraine type 1.
- Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic Stroke.
- Anticoagulation after cardioembolic Stroke: to bridge or not to bridge?
- Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice.
- Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic Stroke.
- Deleterious role of TNF-alpha in retinal ischemia-reperfusion Injury.
- Early release of HMGB-1 from neurons after the onset of Brain ischemia.
- Thunderclap Headache with normal CT and lumbar puncture: further investigations are unnecessary: for.
- Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal Cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome pr...
- A Critique of SAINT II: wishful thinking, dashed hopes, and the future of neuroprotection for acute Stroke.
- Linking Notch signaling to ischemic Stroke.
- Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials.
- NXY-059 for the treatment of Stroke.
- A critical appraisal of the NXY-059 neuroprotection studies for acute Stroke: a need for more rigorous testing of neuroprotective agents in animal models of Stroke.
- Future of neuroprotection for acute Stroke: in the aftermath of the SAINT trials.
- Pitfalls in the diagnosis of cerebellar infarction.
- Vertebral Artery compression of the medulla.
- Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of Transient ischemic attack.
- Telemedicine is crucial to implementing acute Stroke therapy.
- Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute Stroke.
- Vertebrobasilar Disease.
- Cell therapy for Stroke.
- Efficacy of prophylactic antibiotic therapy in Spinal surgery: a meta-analysis.
- Cell transplantation for Stroke.
- Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion Injury.
- Protective effect of Ginkgolids (A+B) is associated with inhibition of NIK/IKK/IkappaB/NF-kappaB signaling pathway in a rat model of permanent focal Cerebral ischemia.
- EDG receptors as a potential therapeutic target in retinal ischemia-reperfusion Injury.
- Diagnosis and initial management of cerebellar infarction.
- Pooled analysis of patients with thunderclap Headache evaluated by CT and LP: is angiography necessary in patients with negative evaluations?
- The complications of cardioembolic Stroke: lessons from the VISTA database.
- Outcome analysis in clinical trial design for acute Stroke: physicians'' attitudes and choices.
- Launching intravenous bone marrow cell trials for acute Stroke.
- Can comprehensive Stroke centers erase the ''weekend effect''?
- Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic Stroke.
- Bone marrow-derived mononuclear cell populations in pediatric and adult patients.
- Recovery after ischemic Stroke: criteria for good outcome by level of disability at day 7.
- Update of the Stroke therapy academic industry roundtable preclinical recommendations.
- Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study.
- Prophylactic neuroprotection.
- Stem cells and Stroke: are we further away than anyone is willing to admit?
- Progenitor cell therapy for the treatment of central nervous system Injury: a review of the state of current clinical trials.
- IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways.
- Various Cell Populations Within the Mononuclear Fraction of Bone Marrow Contribute to the Beneficial Effects of Autologous Bone Marrow Cell Therapy in a Rodent Stroke ...
- Swipe out Stroke: Feasibility and efficacy of using a smart-phone based mobile application to improve compliance with weight loss in obese minority Stroke patients and...
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Bell's Palsy
- Brain Aneurysm
- View All
Doctors Specialties
- Vascular Neurology
- Neurology
Accepted Insurances
Education
-
Beth Israel Deaconess Medical Center -
Albert Einstein College of Medicine of Yeshiva University
Drug Facts
| NPI NUMBER | 1174639173 | |
| NPPES Provider LastName | SAVITZ | |
| NPPES Provider FirstName | SEAN | |
| NPPES Provider ZIPCode | 770303000 | |
| NPPES Provider State | TX | |
| Specialty Description | Neurology | |
| Total Claim Count | 13.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174639173 |
| Last Name Of The Provider | SAVITZ |
| First Name Of The Provider | SEAN |
| View All |
Similar Doctors
|
|
Dr. David Chiu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abraham P. Thomas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose I. Suarez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vasudeva R. Boosupalli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Igor M. Cherches, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary A. Thenganatt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rahul R. Karamchandani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Duaa Jabari, MD |
|
|
Dr. Ninan T. Mathew, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gerard J. Meskill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Holly C. Rutherford, MD
This Doctor is OpenDoctor Recommended.
|